Patents by Inventor Neil C. Bruce

Neil C. Bruce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5571685
    Abstract: A morphinone reductase enzyme and related process provide for the preparation of hydromorphone from morphinone and hydrocodone from neopinone or codeinone. The enzyme has no significant activity with compounds of similar ring structure, has a molecular weight of approximately 81 kilodaltons and is composed of two identical subunits. The enzyme uses NADH as a cofactor and displays no significant enzymatic activity in the reverse direction.
    Type: Grant
    Filed: November 30, 1994
    Date of Patent: November 5, 1996
    Assignee: MacFarlan Smith Limited
    Inventors: Anne M. Hailes, Christopher E. French, Neil C. Bruce
  • Patent number: 5500351
    Abstract: A biosensor for detecting metal ions of elements such as Hg, Cr, As, Tc, Cu, Ag, Se, V, Mo and U which are capable of being reduced to metal by a reductase enzyme. The reductase enzyme is contained in an immobilized enzyme composition also including a cofactor and a coenzyme. The cofactor, for example NADPH, is oxidized by a reaction coupled with the reductase reduction of the metal ions and the cofactor in its oxidized state, e.g., NADP.sup.+, is re-reduced thereby maintaining a supply of the reduced state cofactor by action of the coenzyme in a further oxidation reaction coupled with the cofactor reduction. The further oxidation reaction may be oxidation of an alcohol to an aldehyde brought about by a dehydrogenase coenzyme. The oxidation brought about by the coenzyme, i.e., the amount of oxidized product, is a measure of the amount of oxidized state cofactor produced which, in turn, is a measure of the concentration of metal ions being detected.
    Type: Grant
    Filed: July 18, 1994
    Date of Patent: March 19, 1996
    Assignee: British Nuclear Fuels PLC
    Inventors: Harry Eccles, Geoffrey W. Garnham, Christopher R. Lowe, Neil C. Bruce
  • Patent number: 5462868
    Abstract: A cocaine esterase has been isolated from a strain of the bacteria Pseudomonas maltophilta, The cocaine esterase catalyses the debenzoylation of cocaine, This reaction may be used in the detection of cocaine. The enzyme may be incorporated into sensors for this purpose. The cocaine esterase is preferably obtainable from Pseudomonas sp. NCIMB 40427. It catalyzes the debenzoylation of cocaine, has a molecular weight in the unaggregated form of about 120,000 daltons as determined by gel filtration, has esterase activity specifically at the benzoate ester linkage of cocaine, separates at a major band of Rf about 0.2 on PAGE in its aggregated form, and it is completely inhibited by 1 mM phenylmethylsulphonyl fluoride but ineffectively inhibited by 1 mM eserine, each determined at 30.degree. C. with respect to 2 mM cocaine as substrate.
    Type: Grant
    Filed: January 26, 1994
    Date of Patent: October 31, 1995
    Assignee: British Technology Group Limited
    Inventors: Adrian J. Britt, Neil C. Bruce, Christopher R. Lowe
  • Patent number: 5387515
    Abstract: Two enzymes, one an acetylmorphine carboxyesterase (AMCE), the other a morphine dehydrogenase (MDH), have been isolated from bacteria. The AMCE degrades heroin to morphine and the MDH oxidizes morphine to morphinone, with the aid of a cofactor. More particularly, the invention pertains to a process for preparing a 6-ketone from morphine or a methyl or ethyl derivative thereof. The process comprises oxidizing morphine or an ether derivative in the presence of a morphine dehydrogenase and the cofactor NADP.sup.+. These reactions are used in detection of heroin (using the two reactions coupled together) or morphine. The enzymes can be incorporated in sensors for this purpose.
    Type: Grant
    Filed: January 19, 1994
    Date of Patent: February 7, 1995
    Assignee: British Technology Group Limited
    Inventors: Neil C. Bruce, Lauren D. G. Stephens, Christopher R. Lowe
  • Patent number: 5298414
    Abstract: Two enzymes, one an acetylmorphine carboxyesterase (AMCE), the other a morphine dehydrogenase (MDH), have been isolated from bacteria. The AMCE degrades heroin to morphine and the MDH oxidises morphine to morphinone, with the aid of a cofactor. These reactions are used in detection of heroin (using the two reactions coupled together) or morphine. The enzymes can be incorporated in sensors for this purpose.
    Type: Grant
    Filed: November 12, 1991
    Date of Patent: March 29, 1994
    Assignee: British Technology Group Limited
    Inventors: Neil C. Bruce, Lauren D. G. Stephens, Christopher R. Lowe